|
|
 |
|
Viewing report
|
|
|
|
Synthetic Biology, A New Paradigm For Biological Discovery
Beachhead Consulting, Feb 2006, Pages: 158
Synthetic biology's impact on the healthcare industry is examined in a newly released report, 'Synthetic Biology, A New Paradigm for Biological Discovery', which reveals the market for synthetic biology products and technologies as potentially one of the fastest growing segments of the life sciences market. Although the research market is currently $600M, the potential for growth in the next 10 years is projected to expand this market to over $3.5B. The report is based on in-depth interviews of leading scientific researchers and biotechnology executives and presents the current research and how it may be directly applied to the development of tools and systems for clinical, pharmacological and environmental applications. It also shows that new drug applications discovered through synthetic biology have streamlined the pharmaceutical industry's ability to deliver new therapeutic agents.
ABOUT SYNTHETIC BIOLOGY
What began with DNA cloning is becoming one of the most essential areas of biological research today: synthetic biology. The field of synthetic biology is comprised of experts from different fields of study, such as biochemists, molecular biologists, engineers, and organic chemists, who take existing biological pieces, transform them into micro-machines and create artificial systems that mimic the properties of living systems. By creating systems that mimic what nature has created, scientists can discover the basic principles that rule living systems, manipulate these systems, and eventually find treatments for many diseases plaguing humanity. Today's synthetic biologists are looking to channel genetic engineering from a hit-or-miss field of discovery to the type of discipline used by engineers to build bridges, computers and buildings. This approach can translate into more specific anticancer therapies and anti-viral drugs, as well as more efficient drug delivery systems that will have a significant impact on the healthcare industry.
Customers who bought this item also bought
RNAi - Technologies, Markets and Companies
Antiviral Therapeutics - Technologies, Markets and Companies
Proteomics - Technologies, Markets and Companies
Nanobiotechnology Applications, Markets and Companies
Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics
Gene Therapy - Technologies, Markets and Companies
Drug Delivery in Cancer - Technologies, Markets and Companies
Molecular Diagnostics - Technologies, Markets and Companies
The Future of RNAi Therapeutics: Drug Pipelines and Prospects
Synthetic Biology: An Emerging Tool for Drug Discovery and Production
RNA Interference for Drug R&D: Applications, Alliances, Companies and WW Market to 2011
Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
|
|
|
|
